Tratamiento endovascular del síndrome de vena cava superior

Background: Superior vena cava syndrome (SVCS) is caused by the obstruction of venous drainage from the upper portion of the body. Common clinical findings are headache and cervical, facial and upper limb edema. Occasionally, clouding of consciousness appears. Aim: to report our experience with endo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bergoeing R,Michel, Mertens M,Renato, Valdés E,Francisco, Krämer Sch,Albrecht, Alvarez Z,Manuel, Bertin C,Pablo, Sagüés C,Rodrigo, Orellana U,Eric, Galindo A,Héctor, Vergara G,Jeannette, Valdebenito C,Magaly
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2006
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872006000700004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872006000700004
record_format dspace
spelling oai:scielo:S0034-988720060007000042006-08-29Tratamiento endovascular del síndrome de vena cava superiorBergoeing R,MichelMertens M,RenatoValdés E,FranciscoKrämer Sch,AlbrechtAlvarez Z,ManuelBertin C,PabloSagüés C,RodrigoOrellana U,EricGalindo A,HéctorVergara G,JeannetteValdebenito C,Magaly Angioplasty Stents Superior vena cava syndrome Background: Superior vena cava syndrome (SVCS) is caused by the obstruction of venous drainage from the upper portion of the body. Common clinical findings are headache and cervical, facial and upper limb edema. Occasionally, clouding of consciousness appears. Aim: to report our experience with endovascular treatment of SVCS. Material and methods: Retrospective review of all patients with SVCS subjected to endovascular treatment between 1999 and 2005. Results: Eight patients were treated, all of them with malignancies. Six had a benign obstruction due to the presence of a chemotherapy catheter located in the superior vena cava, one had obstruction secondary to radiation therapy and one a tumor compression of the superior vena cava. Two patients underwent thrombolytic therapy. Angioplasty and stenting was performed in all patients. The chemotherapy catheter was removed to all patients and installed again in one. One patient had a hemothorax secondary to a simultaneous needle lung biopsy under video thoracoscopy. No patient died in relation to the procedure. Congestive signs and symptoms subsided in all patients within 24 hours after the procedure. During follow up, only one patient had symptoms related to vena cava obstruction and three died due to their malignant tumor. Conclusions: Endovascular treatment of SVCS has a low rate of complications and provides immediate and mid-term symptom reliefinfo:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.134 n.7 20062006-07-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872006000700004es10.4067/S0034-98872006000700004
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Angioplasty
Stents
Superior vena cava syndrome
spellingShingle Angioplasty
Stents
Superior vena cava syndrome
Bergoeing R,Michel
Mertens M,Renato
Valdés E,Francisco
Krämer Sch,Albrecht
Alvarez Z,Manuel
Bertin C,Pablo
Sagüés C,Rodrigo
Orellana U,Eric
Galindo A,Héctor
Vergara G,Jeannette
Valdebenito C,Magaly
Tratamiento endovascular del síndrome de vena cava superior
description Background: Superior vena cava syndrome (SVCS) is caused by the obstruction of venous drainage from the upper portion of the body. Common clinical findings are headache and cervical, facial and upper limb edema. Occasionally, clouding of consciousness appears. Aim: to report our experience with endovascular treatment of SVCS. Material and methods: Retrospective review of all patients with SVCS subjected to endovascular treatment between 1999 and 2005. Results: Eight patients were treated, all of them with malignancies. Six had a benign obstruction due to the presence of a chemotherapy catheter located in the superior vena cava, one had obstruction secondary to radiation therapy and one a tumor compression of the superior vena cava. Two patients underwent thrombolytic therapy. Angioplasty and stenting was performed in all patients. The chemotherapy catheter was removed to all patients and installed again in one. One patient had a hemothorax secondary to a simultaneous needle lung biopsy under video thoracoscopy. No patient died in relation to the procedure. Congestive signs and symptoms subsided in all patients within 24 hours after the procedure. During follow up, only one patient had symptoms related to vena cava obstruction and three died due to their malignant tumor. Conclusions: Endovascular treatment of SVCS has a low rate of complications and provides immediate and mid-term symptom relief
author Bergoeing R,Michel
Mertens M,Renato
Valdés E,Francisco
Krämer Sch,Albrecht
Alvarez Z,Manuel
Bertin C,Pablo
Sagüés C,Rodrigo
Orellana U,Eric
Galindo A,Héctor
Vergara G,Jeannette
Valdebenito C,Magaly
author_facet Bergoeing R,Michel
Mertens M,Renato
Valdés E,Francisco
Krämer Sch,Albrecht
Alvarez Z,Manuel
Bertin C,Pablo
Sagüés C,Rodrigo
Orellana U,Eric
Galindo A,Héctor
Vergara G,Jeannette
Valdebenito C,Magaly
author_sort Bergoeing R,Michel
title Tratamiento endovascular del síndrome de vena cava superior
title_short Tratamiento endovascular del síndrome de vena cava superior
title_full Tratamiento endovascular del síndrome de vena cava superior
title_fullStr Tratamiento endovascular del síndrome de vena cava superior
title_full_unstemmed Tratamiento endovascular del síndrome de vena cava superior
title_sort tratamiento endovascular del síndrome de vena cava superior
publisher Sociedad Médica de Santiago
publishDate 2006
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872006000700004
work_keys_str_mv AT bergoeingrmichel tratamientoendovasculardelsindromedevenacavasuperior
AT mertensmrenato tratamientoendovasculardelsindromedevenacavasuperior
AT valdesefrancisco tratamientoendovasculardelsindromedevenacavasuperior
AT kramerschalbrecht tratamientoendovasculardelsindromedevenacavasuperior
AT alvarezzmanuel tratamientoendovasculardelsindromedevenacavasuperior
AT bertincpablo tratamientoendovasculardelsindromedevenacavasuperior
AT saguescrodrigo tratamientoendovasculardelsindromedevenacavasuperior
AT orellanaueric tratamientoendovasculardelsindromedevenacavasuperior
AT galindoahector tratamientoendovasculardelsindromedevenacavasuperior
AT vergaragjeannette tratamientoendovasculardelsindromedevenacavasuperior
AT valdebenitocmagaly tratamientoendovasculardelsindromedevenacavasuperior
_version_ 1718436269621510144